Small Business Technology Transfer (STTR)
Summary A companion program to SBIR that differs only in the requirement that work must be performed by small businesses in collaboration with non-profit research organizations.
Manager Army Research Office
Web Sites
Program Process
  • Army advertises interest in specific research topics
  • Small business – non-profit R&D collaborators offer proposals addressing topics
  • Successful proposals awarded Phase I support for 6 months’ work
  • Successful Phase I projects compete for 2 years’ additional support in Phase II
Technology Maturity Level Basic science and early developmental work.
Award Size Phase I, up to $100K; Phase II, up to $500K.
Program Size $8M in FY01; about 15 new Phase I and 10 Phase II projects.
Format Requirements for Topic Submission USAMRMC submits relatively short (1-2 page) narratives describing proposed Phase I topics.
Criteria for Selecting Topics
  • Linked to the Objective Force, Army STOs
  • Cannot be used simply to fill gaps in normal program
  • Must allow contractor reasonable degree of independence
  • Must require contractor innovation
Criteria for Selecting Proposals
  • Military relevance
  • Technical merit, innovation
  • Potential for commercial exploitation
  • Staff qualifications
USAMRMC Participation
  • Develop candidate topics for Phase I
  • Review proposals for Phase I, Phase II
  • Monitor projects during execution
Calendar
Topic Phase I Phase II
USAMRMC closing date for topic ideas Sept N/A
USAMRMC topic submissions to ARO Oct N/A
Public solicitation opens Mar Feb
Public solicitation closes Apr Apr
USAMRMC closing date for proposal reviews May May
Awards announced Jun Jun
USAMRMC Recent History About one or two topics and one Phase I award per year.
Comments Program has high visibility with Congress, financed by a tax on all 6.1 – 6.3 research funds.
Examples
  • Telemedicine and Advanced Medical Technology - Medical/Surgical, Mission Support Modeling and Simulation
  • Development of a Multivalent Oral Vaccine for Traveler’s Diarrhea
  • Development of Potential Therapeutic Compounds for Enhanced Membrane Permeability and Cholinergic Nerve Terminal Targeting
  • Next Generation Long-term Electroencephalogram Recording Devices for Mice
  • Development of Potential Therapeutic Compounds for Enhanced Membrane Permeability and Cholinergic Nerve Terminal Targeting
  • Activatible Molecular Structure Probes for Biological Detection
  • Advanced Direct Methanol Fuel Cell MEAs
  • High-performance Layer Geometry for Damage Tolerance
  • Biocatalytic Polymer Skin Adhesives
  • Activated Organophosphate Hydrolase for Coupling to Human Skin